any investor wanting to learn who is a decoy (and i'll

New Post Public Reply Private Reply Replies (1) Message Board
4kids 4kids #3694
243
any investor wanting to learn who is a decoy (and i'll follow this post with some RT notes from today's activated *decoys*) .. has to learn to note who *shows* vs who *reports* via the MM Monthly

http://otce.finra.org/MonthlyShareVolume

i tend to focus on the daily signals (and where placed on l2) provided by the PRIMARY/SECONDARY and TERTIARY MMs' reporting to Finra

Below are the 3 MMs' who *factually* reported activity to Finra since this time last year .. May 2017 to April 2018 .. as well as the number of MMs' *participating per month* and *volume by month*

you can clearly see who the PRIMARY/SECONDARY and TERTIARY MMs' are re: IPIX

this is important in understanding the role decoys' play in regards to what l2 *shows* on any given day but mostly as is always the case with an *imo* OTC SURVIVOR .. what is revealed over weeks/months and in some cases .. years

that is also why i can note which MM .. is usually acting as a decoy on l2 ..

note exactly the volume done per month (which is why you can see these same
Marker Manipulators lying in regards to *avg* daily volume .. as has been noted
via *legal* as being in the 500k range) .. that remains factually false .. it's closer
to 200k on any given week recently .. but what is really worth noting is who doesn't deviate from the first 3 spots .. each and every month .. you can also observe the fact of *decoys* willing to play the UPSIDE DOWN GAME .. with MMs' (back in 2015 .. running 25 to 29) ..MMs now *reporting* between 9 to 11 for IPIX (13 for May 17 .. CTIX) .. are *actually decreasing*

as i've always noted *volume* tells the tale of where in the cycle NR and CEs *are*

volume will relo UP the 10 and 90 day avgs .. but will a price (daily reg sho % marked) have to paid?

the other fact that can't be ignored to suit is the %s' posted by only 3 MMs every month .. since May 2017 .. 69% to 87% reveals why the round robining rotation of *volume* reported is well in hand by just 3 MMs CON tinues to ramp upwards

make no mistake an educated retail investor is a colluding entity's worst NITE mare (pun intended)

APRIL 2018 .. IPIX Volume ~ 4,473,436
10 MMs' reporting ..
( ETRF/NITE @ 27% .. CDEL @ 20% ) .. total = 75.16% of *volume*
( ARCA .. OTCX .. CSTI @ 9% .. 8% and 4% )
( CANT .. LAFC .. PUMA .. STXG all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 4,473,436 4,078,577 17,073,621 ETRF G1 EXECUTION SVCsETRF, LLC 1,240,454 1 27.73%
IPIX Innovation Pharma 4,473,436 4,078,577 17,073,621 NITE VIRTU AMERICAS LLC 1,216,167 2 27.19%
IPIX Innovation Pharma 4,473,436 4,078,577 17,073,621 CDEL CITADEL SECURITIES LLC 905,353 3 20.24%



MARCH 2018 .. IPIX Volume ~ 4,078,577
11 MMs' reporting ..
( ETRF/CDEL/NITE @ 30% ..24% .. 22% ) .. total = 77.55% of *volume*
( ARCA & CSTI @ 10% and 5% )
( OTCX .. LAFC .. CANT .. VERT .. MAXM .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 4,078,577 3,388,387 12,600,185 ETRF G1 EXECUTION SVCs, LLC 1,247,854 1 30.6%
IPIX Innovation Pharma 4,078,577 3,388,387 12,600,185 CDEL CITADEL SECURITIES LLC 1,004,220 2 24.62%
IPIX Innovation Pharma 4,078,577 3,388,387 12,600,185 NITE VIRTU AMERICAS LLC 910,681 3 22.33%


FEBRUARY 2018 .. IPIX Volume ~ 3,388,387
10 MMs' reporting ..
( ETRF @ 34% .. NITE & CDEL @ 24% ) .. total = 83.04% of *volume*
( ARCA .. CSTI .. LAFC @ 6% .. 4% and 3% )
( CANT .. VERT .. PUMA .. VNDM all sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 3,388,387 5,133,221 8,521,608 ETRF G1 EXECUTION SVCs, LLC 1,152,418 1 34.01%
IPIX Innovation Pharma 3,388,387 5,133,221 8,521,608 NITE VIRTU AMERICAS LLC 838,168 2 24.74%
IPIX Innovation Pharma 3,388,387 5,133,221 8,521,608 CDEL CITADEL SECURITIES LLC 822,921 3 24.29%



JANUARY 2018 .. IPIX Volume ~ 5,133,221
9 MMs' reporting ..
( NITE @ 33% .. ETRF @ 25% .. CDEL @ 23% ) .. total = 82.27% of *volume*
( ARCA .. CSTI .. LAFC @ 6% .. 5% .. 2% )
( CANT .. PUMA .. MAXM .. all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume


 
IPIX Innovation Pharma 5,133,221 8,121,069 5,133,221 NITE VIRTU AMERICAS LLC 1,721,407 1 33.53%
IPIX Innovation Pharma 5,133,221 8,121,069 5,133,221 ETRF G1 EXECUTION SVCs, LLC 1,296,054 2 25.25%
IPIX Innovation Pharma 5,133,221 8,121,069 5,133,221 CDEL CITADEL SECURITIES LLC 1,206,032 3 23.49%



DECEMBER 2017 .. IPIX Volume ~ 8,121,069
11 MMs' reporting ..
( NITE @ 35% .. CDEL @ 23% .. ETRF @ 18% ) .. total = 76.89% of *volume*
( ARCA .. CSTI .. LAFC .. CANT @ 8% .. 6% .. 3% .. 2% )
( VERT .. MAXM .. INTL .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 8,121,069 4,031,082 62,497,265 NITE VIRTU AMERICAS LLC 2,886,476 1 35.54%
IPIX Innovation Pharma 8,121,069 4,031,082 62,497,265 CDEL CITADEL SECURITIES LLC 1,896,344 2 23.35%
IPIX Innovation Pharma 8,121,069 4,031,082 62,497,265 ETRF G1 EXECUTION SVCs, LLC 1,461,977 3 18%



NOVEMBER 2017 .. IPIX Volume ~ 4,031,082
11 MMs' reporting ..
( NITE @ 31% .. ETRF @ 25% .. CDEL @ 22% ) = total of 79.71% of *volume*
( VERT/CANT/ARCA/LAFC/CSTI .. @ 6% .. 4% .. 3% .. 3% .. 2% )
( PUMA .. MAXM .. AEXG all sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 4,031,082 3,856,915 54,376,196 NITE VIRTU AMERICAS LLC 1,283,920 1 31.85%
IPIX Innovation Pharma 4,031,082 3,856,915 54,376,196 ETRF G1 EXECUTION SVCs, LLC 1,032,596 2 25.62%
IPIX Innovation Pharma 4,031,082 3,856,915 54,376,196 CDEL CITADEL SECURITIES LLC 896,653 3 22.24%



OCTOBER 2017 .. IPIX Volume ~ 3,856,915
11 MMs' reporting ..
( NITE .. ETRF .. CDEL @ 33% .. 27% .. 25% ) .. total = 87.51% of *volume*
( LAFC .. CSTI .. VERT @ 3% .. 3% .. 2% )
( CANT .. STXG .. VNDM .. PUMA .. MAXM all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 3,856,915 2,395,379 50,345,114 NITE VIRTU AMERICAS LLC 1,304,156 1 33.81%
IPIX Innovation Pharma 3,856,915 2,395,379 50,345,114 ETRF G1 EXECUTION SVCs, LLC 1,068,898 2 27.71%
IPIX Innovation Pharma 3,856,915 2,395,379 50,345,114 CDEL CITADEL SECURITIES LLC 1,002,365 3 25.99%



SEPTEMBER 2017 .. IPIX Volume ~ 2,395,379
9 MMs' reporting ..
( NITE .. ETRF .. CDEL @ 33% .. 25% .. 21% ) .. total = 80.32% of *volume*
( VERT .. CSTI .. CANT @ 12% .. 3% .. 2% )
( LAFC .. ARCA .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 2,395,379 3,276,355 46,488,199 NITE VIRTU AMERICAS LLC 807,293 1 33.7%
IPIX Innovation Pharma 2,395,379 3,276,355 46,488,199 ETRF G1 EXECUTION SVCs, LLC 603,325 2 25.19%
IPIX Innovation Pharma 2,395,379 3,276,355 46,488,199 CDEL CITADEL SECURITIES LLC 513,444 3 21.43%



AUGUST 2017 .. IPIX Volume ~ 3,276,355
9 MMs' reporting ..
( NITE .. CDEL .. ETRF @ 33% .. 29% .. 21% ) .. total = 84.14% of *volume*
( VERT @ 9% )
( LAFC .. CANT .. CSTI all @ 2% )
( PUMA .. VNDM @ sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 3,276,355 4,896,207 44,092,820 NITE VIRTU AMERICAS LLC 1,099,604 1 33.56%
IPIX Innovation Pharma 3,276,355 4,896,207 44,092,820 CDEL CITADEL SECURITIES LLC 959,917 2 29.3%
IPIX Innovation Pharma 3,276,355 4,896,207 44,092,820 ETRF G1 EXECUTION SVCs, LLC 697,321 3 21.28%



JULY 2017 .. IPIX Volume ~ 4,896,207
10 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 35% .. 31% .. 12% ) .. total = 80.42% of *volume*
( CSTI/CANT @ 6% per .. CANT .. LAFC @ 4% .. 2% )
( ARCA PUMA MAXM all @ sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 4,896,207 6,863,055 40,816,465 CDEL CITADEL SECURITIES LLC 1,752,747 1 35.8%
IPIX Innovation Pharma 4,896,207 6,863,055 40,816,465 NITE VIRTU AMERICAS LLC 1,559,023 2 31.84%
IPIX Innovation Pharma 4,896,207 6,863,055 40,816,465 ETRF G1 EXECUTION SVCs, LLC 625,666 3 12.78%



JUNE 2017 (note now IPIX) .. IPIX Volume ~ 6,863,055
11 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 37% .. 30% .. 12% ) .. total = 80.50% of *volume*
( CSTI .. CANT .. LAFC .. @ 8% .. 4% .. 3% )
( ARCA .. MAXM .. PUMA .. VNDM .. MICA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
IPIX Innovation Pharma 6,863,055 5,182,012 35,920,258 CDEL CITADEL SECURITIES LLC 2,569,233 1 37.44%
IPIX Innovation Pharma 6,863,055 5,182,012 35,920,258 NITE KCG AMERICAS LLC 2,078,242 2 30.28%
IPIX Innovation Pharma 6,863,055 5,182,012 35,920,258 ETRF G1 EXECUTION SVCs, LLC 877,231 3 12.78%



MAY 2017 .. CTIX ( 52 week low *reset* to 63c on 5.10.17 ) Volume ~ 5,182,012
13 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 43% .. 14% .. 11% ) .. total = 69.69% of *volume*
( ARCA & CSTI @ 10% .. CANT @ 5% )
( ARXS .. PUMA .. LAFC .. STXG .. VNDM .. MAXM .. FTBR all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
CTIX Cellceutix Corp 5,182,012 6,320,318 29,057,203 CDEL CITADEL SECURITIES LLC 2,254,605 1 43.51%
CTIX Cellceutix Corp 5,182,012 6,320,318 29,057,203 NITE KCG AMERICAS LLC 736,389 2 14.21%
CTIX Cellceutix Corp 5,182,012 6,320,318 29,057,203 ETRF G1 EXECUTION SVCs, LLC 620,365 3 11.97%



none of this data is difficult to digest .. but it is time consuming which imo is exactly what NR counts on with *retail*

http://otce.finra.org/MonthlyShareVolume

note tho' the *lowest* % was a year ago May b4 mgmt's UPSIDE surprise of June 2017 .. note the following months' %s .. and then compare against PPS *relentless* compression in alignment with a *reduced* volume avg .. (i.e. NRs' Struggle to pry IPIX shares)

folks should also remember that the *legal* data reported in May 2017 vs July 2017 ..

Settlement Date
Issue Name
Symbol
Market
Current Short
Previous Short
Chg
% Change from Prev
Avg Daily Vol
Days to Cover


 
05/15/2017 Cellceutix Corp CTIX 1,037,384 875,733 161,651 18.46 354,459 2.93
05/31/2017 Cellceutix Corp CTIX 1,161,877 1,037,384 124,493 12 579,670 2

 
06/15/2017 Innovation Pharma IPIX 1,234,237 1,161,877 72,360 6.23 650,213 1.9
06/30/2017 Innovation Pharma IPIX 1,458,432 1,234,237 224,195 18.16 594,048 2.46
07/14/2017 Innovation Pharma IPIX 1,302,241 1,458,432 -156,191 -10.71 609,859 2.14
07/31/2017 Innovation Pharma IPIX 1,206,257 1,302,241 -95,984 -7.37 389,777 3.09


now note what the most recent (next set of dated data due out ah's on 5.24.18)
*legal* reported .. and take note of the avg daily volume *reported* re: IPIX .. from 2017 to this past month .. note .. it bears zero resemblance to being factual perhaps it's a *tell* or NR is projecting *intent* re: IPIX *volume* ..

 
04/30/2018 Innovation Pharma IPIX 1,113,653 1,131,509 -17,856 -1.58 536,933 2.07


http://otce.finra.org/ESI

4kids

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Innovative CORDStrom™ Platform by INmune Bio

Updated Category News Views 200

Introduction to CORDStrom™ and Its Significance INmune Bio, Inc. (NASDAQ: INMB), a pioneer in the field of inflammation and immunology therapies, has recently sparked significant interest in the medical community. Their intriguing CORDStrom™ platform signifies a promising advance in mesenchymal stromal cell (MSC) therapies, aiming to address various health conditions...

Continue Reading
Brooklyn Law School Enhances Scholarship Support for Veterans

Updated Category News Views 156

Brooklyn Law School Expands Support for Veteran Students Brooklyn Law School has taken significant steps to demonstrate its commitment to veterans by increasing scholarship support, ensuring they receive the assistance they need to excel in their legal education. This initiative reflects a profound recognition of the sacrifices made by our armed forces members and aims to...

Continue Reading
Unlocking Creativity with the New vivo X200 FE Smartphone

Updated Category News Views 441

Introducing the vivo X200 FE: Ideal for the Innovative Generation Vivo proudly announces the launch of the X200 FE, a cutting-edge smartphone designed with the vibrant essence of the new generation in mind. This model combines playful aesthetics with dependable functionality, delivering an exceptional user experience. With its striking color-blocking design and advanced...

Continue Reading
Exploring Market Sentiment Towards Westinghouse Air Brake Tech

Updated Category News Views 201

Current Sentiment Around Westinghouse Air Brake Technologies Corp Westinghouse Air Brake Technologies Corp (NYSE: WAB) is a prominent player in the transportation industry, particularly known for its innovation in braking systems and other technology. Recently, it has come to light that the short interest as a percentage of its float has decreased significantly, by...

Continue Reading
Asante Gold Highlights Shareholder Meeting Information and Voting

Updated Category News Views 165

Key Information about Asante Gold's Upcoming Shareholder Meeting Your participation is crucial, regardless of how many shares you own in Asante Gold. The Company’s Board of Directors strongly advises all shareholders to vote for all resolutions presented. Proxy Materials Available Online Asante Gold Corporation (TSXV: ASE | GSE: ASG | OTCQX: ASGOF) has announced that...

Continue Reading